0001493152-21-002451.txt : 20210203
0001493152-21-002451.hdr.sgml : 20210203
20210203073756
ACCESSION NUMBER: 0001493152-21-002451
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201221
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roberts Brad Michael
CENTRAL INDEX KEY: 0001844066
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 21584208
MAIL ADDRESS:
STREET 1: 300 CHAFFORD COURT
CITY: SIMPSONVILLE
STATE: SC
ZIP: 29681
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONVERSION LABS, INC.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
3
1
ownership.xml
X0206
3
2020-12-21
0
0000948320
CONVERSION LABS, INC.
CVLB
0001844066
Roberts Brad Michael
C/O CONVERSION LABS, INC,
800 THIRD AVENUE, SUITE 2800
NEW YORK
NY
10022
0
1
0
0
Chief Operating Officer
Restricted Stock Units
10000
D
Options to purchase shares of Common Stock
Common Stock, par value $0.001
200000
D
Pursuant to the terms of the amended and restated employment agreement, by and between Mr. Roberts and the Issuer, on January 8, 2021 (the "Effective Date"), Mr. Roberts was granted: (i) 10,000 restricted stock units of the Company's common stock (the "RSUs") which shall vest on December 21, 2021; and (ii) stock options to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.50 per share (the "Stock Options"). 35,000 of the Stock Options vested on the Effective Date, with the remaining Stock Options scheduled to vest in equal monthly tranches, based on the passage of time, over the 30 months following the approval of the Effective Date.
/s/ Brad Roberts
2021-02-03